A prospective study of aspirin use and prostate cancer risk by TMPRSS2:ERG status

BACKGROUND: In a case-control study, aspirin use was associated with a lower risk of a common prostate cancer molecular subtype, the TMPRSS2:ERG gene fusion. We sought to validate this finding in a prospective cohort. METHODS: In the Health Professionals Follow-up Study, 49,395 men reported on aspir...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Epidemiol Biomarkers Prev
Main Authors: Stopsack, Konrad H., Gonzalez-Feliciano, Amparo G., Peisch, Samuel F., Downer, Mary K., Gage, Riley A., Finn, Stephen, Lis, Rosina T., Graff, Rebecca E., Pettersson, Andreas, Pernar, Claire H., Loda, Massimo, Kantoff, Philip W., Ahearn, Thomas U., Mucci, Lorelei A.
Format: Artigo
Language:Inglês
Published: 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6170677/
https://ncbi.nlm.nih.gov/pubmed/30108097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-18-0510
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items